Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
Top Cited Papers
- 28 March 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 37 (5), 1228-1233
- https://doi.org/10.1016/s0735-1097(01)01116-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1European Heart Journal, 1999
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1995
- Biological Determinants of Aldosterone-Induced Cardiac Fibrosis in RatsHypertension, 1995
- The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarctionThe American Journal of Cardiology, 1995
- Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosisThe American Journal of Cardiology, 1995
- Mineralocorticoids, hypertension, and cardiac fibrosis.Journal of Clinical Investigation, 1994
- Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertensionThe American Journal of Cardiology, 1993
- Captopril in heart failure. A double blind controlled trial.Heart, 1984
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978